BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription
AUTOR(ES)
Shin, Sook
FONTE
National Academy of Sciences
RESUMO
Germ-line mutations of the BRCA2 tumor suppressor gene greatly increase the risk of developing breast and ovarian cancers. Here, we show that wild-type BRCA2, but not a tumor-specific truncated mutant BRCA2, synergizes with the nuclear receptor coactivator p160 GRIP1 to enhance transcriptional activation by androgen receptor (AR). BRCA2 not only associates with AR and GRIP1 but also cooperates with both the histone acetyltransferase P/CAF and BRCA1 to enhance AR- and GRIP1-mediated transactivation. As such, BRCA2 can exert its tumor suppressor function, in part, by modulating androgen signaling, which has been shown to be antiproliferative in a subset of breast cancer cells and particularly implicated in male breast tumors.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=165853Documentos Relacionados
- CREB-binding protein in androgen receptor-mediated signaling
- Inhibition of Androgen Receptor-Mediated Transcription by Amino-Terminal Enhancer of split
- Requirement of Histone Methyltransferase SMYD3 for Estrogen Receptor-mediated Transcription*
- Androgen receptor–mediated inhibition of cutaneous wound healing
- Histone H1 Represses Estrogen Receptor α Transcriptional Activity by Selectively Inhibiting Receptor-Mediated Transcription Initiation